News and Activities
Hot Off The Press.
Press Releases
Acclaimed Dentistry Leader Dr. Ed Zuckerberg Joins Proteocyte in Advisory Role
Toronto, ON; November 15, 2022 - Proteocyte AI, a company dedicated to producing a range of technological solutions that predict a patient's risk of developing oral cancer, is pleased to welcome Dr. Ed Zuckerberg as a Senior Advisor. Joining the company to advance the commercialization process of...
Proteocyte Reaches Regulatory Approval Milestone with ISO 15189 Accreditation
Toronto, ON; March 17, 2022 - Proteocyte AI, a company dedicated to producing a range of technological solutions that predict a patient's risk of developing oral cancer, has reached an important milestone in the regulatory process for Straticyte™, its first commercial offering. The company...
Proteocyte Announces Mark Hammar as new CEO
Toronto, ON; January 19, 2022 - Proteocyte AI, a company dedicated to producing a range of technological solutions that predict a patient's risk of developing oral cancer, is pleased to announce the appointment of Mark Hammar as Chief Executive Officer, effective immediately. Mr. Hammar is taking...
Proteocyte Selects Medlior as Health Outcomes Research Provider
MaRS Discovery District, Toronto, ON; December 1, 2021 - Proteocyte AI is pleased to announce its formal engagement with Medlior, a health outcomes research provider based in Calgary, Alberta. Proteocyte will rely on Medlior's team of diverse subject matter experts to bring scientific expertise,...